Klenke, Frank M; Wenger, Doris E; Inwards, Carrie Y; Rose, Peter S; Sim, Franklin H (2011). Giant cell tumor of bone: risk factors for recurrence. Clinical orthopaedics and related research, 469(2), pp. 591-9. Heidelberg: Springer 10.1007/s11999-010-1501-7
|
Text
Giant_Cell_Tumor_of_Bone__Risk_Factors_for.38.pdf - Published Version Available under License Publisher holds Copyright. Download (276kB) | Preview |
Many surgeons treat giant cell tumor of bone (GCT) with intralesional curettage. Wide resection is reserved for extensive bone destruction where joint preservation is impossible or when expendable sites (eg, fibular head) are affected. Adjuvants such as polymethylmethacrylate and phenol have been recommended to reduce the risk of local recurrence after intralesional surgery. However, the best treatment of these tumors and risk factors for recurrence remain controversial.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Orthopaedic Surgery |
UniBE Contributor: |
Klenke, Frank M. |
ISSN: |
0009-921X |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:22 |
Last Modified: |
05 Dec 2022 14:06 |
Publisher DOI: |
10.1007/s11999-010-1501-7 |
PubMed ID: |
20706812 |
Web of Science ID: |
000286939300038 |
BORIS DOI: |
10.48350/7423 |
URI: |
https://boris.unibe.ch/id/eprint/7423 (FactScience: 212683) |
Actions (login required)
 |
Edit item |